Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126994511 | 12699451 | 1 | I | 20071203 | 20071205 | 20160830 | 20160830 | EXP | US-PFIZER INC-2007102006 | PFIZER | 64.00 | YR | F | Y | 112.93000 | KG | 20160830 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126994511 | 12699451 | 1 | SS | NAPROXEN. | NAPROXEN | 1 | Oral | UNK | Y | 0 | TABLET | ||||||||
| 126994511 | 12699451 | 2 | SS | NAPROXEN. | NAPROXEN | 1 | Y | 0 | TABLET | ||||||||||
| 126994511 | 12699451 | 3 | PS | DILTIAZEM HCL | DILTIAZEM HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK | Y | 74941 | |||||||||
| 126994511 | 12699451 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | UNK, 1X/DAY | 0 | QD | |||||||||
| 126994511 | 12699451 | 5 | C | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 126994511 | 12699451 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 126994511 | 12699451 | 7 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | UNK | 0 | ||||||||||
| 126994511 | 12699451 | 8 | C | ZOCOR | SIMVASTATIN | 1 | Oral | UNK | 0 | ||||||||||
| 126994511 | 12699451 | 9 | C | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | 25 MG, 2X/DAY | 0 | 25 | MG | BID | |||||||
| 126994511 | 12699451 | 10 | C | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | 50 MG, 2X/DAY | 0 | 50 | MG | BID | |||||||
| 126994511 | 12699451 | 11 | C | DIOVAN | VALSARTAN | 1 | Oral | UNK | 0 | ||||||||||
| 126994511 | 12699451 | 12 | C | AVANDIA | ROSIGLITAZONE MALEATE | 1 | Oral | UNK | 0 | ||||||||||
| 126994511 | 12699451 | 13 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | UNK | 0 | ||||||||||
| 126994511 | 12699451 | 14 | C | ASPIRIN. | ASPIRIN | 1 | Oral | UNK | 0 | ||||||||||
| 126994511 | 12699451 | 15 | C | TRAMADOL. | TRAMADOL | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126994511 | 12699451 | 1 | Osteoarthritis |
| 126994511 | 12699451 | 2 | Rheumatoid arthritis |
| 126994511 | 12699451 | 3 | Ventricular tachycardia |
| 126994511 | 12699451 | 4 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126994511 | 12699451 | LT |
| 126994511 | 12699451 | OT |
| 126994511 | 12699451 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126994511 | 12699451 | Atrial fibrillation | |
| 126994511 | 12699451 | Drug hypersensitivity | |
| 126994511 | 12699451 | Intertrigo | |
| 126994511 | 12699451 | Pharyngitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126994511 | 12699451 | 1 | 20070926 | 20071204 | 0 | |
| 126994511 | 12699451 | 3 | 20071205 | 20071205 | 0 | |
| 126994511 | 12699451 | 4 | 20070926 | 20071204 | 0 | |
| 126994511 | 12699451 | 5 | 200704 | 0 | ||
| 126994511 | 12699451 | 6 | 1992 | 0 | ||
| 126994511 | 12699451 | 7 | 1992 | 0 | ||
| 126994511 | 12699451 | 8 | 2005 | 0 | ||
| 126994511 | 12699451 | 9 | 2006 | 20071205 | 0 | |
| 126994511 | 12699451 | 10 | 20071206 | 0 | ||
| 126994511 | 12699451 | 11 | 2006 | 0 | ||
| 126994511 | 12699451 | 12 | 2006 | 0 | ||
| 126994511 | 12699451 | 13 | 1988 | 0 | ||
| 126994511 | 12699451 | 14 | 2006 | 20071206 | 0 | |
| 126994511 | 12699451 | 15 | 20070927 | 0 |